AtaiBeckley ATAI
NASDAQ ATAI
$7.40 +0.06 (+0.82%)
As of: Sep 4, 2026 · 3:17 PM EDT

AtaiBeckley (ATAI) Operating Margin Growth (3y) (2024 - 2025)

Analysis

AtaiBeckley (ATAI) Operating Margin Growth (3y) (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn -204.00
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 7,045.00
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -1,934.00
5 Revolution Medicines 44.02 Bn 44.02 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 7,261.00
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 9,003.00
8 Royalty Pharma 28.43 Bn 27.59 Bn - -2,649.00
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 30,461.00
10 AtaiBeckley 1.61 Bn 1.61 Bn - 15.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 15.63 Mn
Jun 30, 2025 1.73 Mn
Dec 31, 2024 -23.26 Mn
Sep 30, 2024 -4.40 Mn